November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Statement on Trump Pullback of Medicaid Flexibility
- Wyden Condemns Trump DOJ for Abandoning Case Protecting Emergency Abortion Care at Hospitals
- Wyden Blasts Trump Tariffs, Urges Bipartisan Support of Bill to Protect Consumers from Trade War
- Wyden Statement on Senseless Trump Tariffs on Products from Canada, Mexico and China
- Wyden Statement on Trump Administration Ending Enforcement of Key Anti-Money Laundering Law